Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, February 2000, p. 418-420, Vol. 44, No. 2
0066-4804/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Role of the PDR Gene Network in Yeast
Susceptibility to the Antifungal Antibiotic Mucidin
Dana
Michalkova-Papajova,
Margita
Obernauerova, and
Julius
Subik*
Department of Microbiology and Virology,
Faculty of Natural Sciences, Comenius University, 842 15 Bratislava, Slovak Republic
Received 22 April 1999/Returned for modification 12 October
1999/Accepted 1 November 1999
 |
ABSTRACT |
Yeast strains disrupted in the PDR1, PDR3,
or PDR5 gene, but not in SNQ2, exhibited higher
sensitivity to mucidin (strobilurin A) than did the isogenic wild-type
strains. Different gain-of-function mutations in the PDR1
and PDR3 genes rendered yeast mutants resistant to this
antibiotic. Mucidin induced PDR5 expression, but the
changes in the expression of SNQ2 were only barely
detectable. The results indicate that PDR5 provides the
link between transcriptional regulation by PDR1 and
PDR3 and mucidin resistance of yeast.
 |
TEXT |
The antifungal antibiotic mucidin
(strobilurin A) has been successfully used in clinical treatment of
dermatomycoses (7) and has become a valuable tool in
biochemical and molecular genetic studies with yeasts (10).
Mucidin specifically inhibits electron transport in the cytochrome
bc1 complex of the mitochondrial respiratory chain (16). Resistance to mucidin in the yeast
Saccharomyces cerevisiae results from mutations mapping in
either mitochondrial or nuclear genes (17). The nuclear
mucidin-resistant mutants displayed a pleiotropic drug resistance
phenotype due to the mutations in the PDR3 gene (17,
18). This gene has been cloned, sequenced (4), and
subjected to mutational analysis (13). It specifies a
transcriptional activator homologous to that encoded by the PDR1 gene (4). PDR1 and
PDR3 together with the drug efflux pump-encoding genes like
PDR5 and SNQ2 create the PDR network of genes
(8) which, together with another network of stress response
genes activated by the transcription factor YAP1
(11), are involved in multiple drug resistance in S. cerevisiae. Their homologues were also identified in the yeast
Candida albicans and contribute significantly to the
fungicide resistance of this most prominent fungal pathogen of humans
(15).
The aim of the present study was to analyze the molecular mechanisms of
mucidin susceptibility in S. cerevisiae using different mutants of the PDR network of genes involved in yeast multidrug resistance.
The strains of S. cerevisiae used in this study were derived
from the wild-type strains FY1679-28C (MATa
ura3-52 trp1
63 leu2
1 his3
200) (1, 4) and
YPH500 (MAT
ura3-52 trp1
63 leu2
1 his3
200
lys2-801amb ade2-101ochr) (9).
The PDR3 gene and its mutant alleles were cloned on centromeric plasmid pFL38-PP3 (ARS1 CEN4 URA3 PDR3) under
the control of its promoter (13). Six mutant alleles
(pdr3-4 to pdr3-11) contained gain-of-function
mutations in the N terminus (13), and another six mutant
alleles (pdr3-15 to pdr3-20) contained mutations
in the C-terminal moiety of PDR3 (J. Subik, A. Nourani, A. Delahodde, T. Simonic, V. Subikova, and C. Jacq, Abstr.
Sixth Int. Mycol. Congr., p. 19, 1998). Yeast strains were grown in YPGE medium (1% Bacto Peptone, 1% yeast extract, 2% glycerol, and
2% ethanol) or in a minimal medium containing 0.67% yeast nitrogen
base without amino acids and 2% glucose or 2% glycerol plus 2%
ethanol. The appropriate nutritional requirements and drugs were added
at the indicated concentrations. Solid media were prepared with 2%
agar. Bacterial strains were grown in Luria-Bertani medium supplemented
with ampicillin at 50 µg/ml.
Plasmid DNA from Escherichia coli TG1 cells was prepared by
the alkaline lysis method and used to transform S. cerevisiae as described previously (13). The
sensitivity of yeast cells to mucidin was assayed by measuring the MICs
(13) and by determination of growth inhibition zones on the
solid YPGE medium (17). Mucidin resistance of a set of
independent transformants was scored for each of the DNA constructs
after 5 to 12 days of growth at 30°C.
The abundance of Pdr5p and Snq2p in total yeast extracts was determined
by Western blot analysis as described previously (5). Equivalent protein loading in each lane was verified by probing the
immunoblots with polyclonal antibodies against Pgk1p. The level of
Pdr5p after mucidin response was quantitated by densitometric scanning
of the developed film using Pharmacia Biotech ImageMaster 1D software.
The susceptibility of the yeast S. cerevisiae to mucidin was
studied using the isogenic sets of mutants derived from two wild-type strains, FY1679-28C and YPH500. It was found that the strains with the
disrupted PDR1 or PDR3 gene were significantly
more sensitive to mucidin than a corresponding wild-type strain (Fig.
1A). The disruption of both
PDR1 and PDR3 led to the highest level of mucidin sensitivity, indicating that the two transcriptional activators play a
significant role in the control of mucidin susceptibility of yeast
cells.

View larger version (21K):
[in this window]
[in a new window]
|
FIG. 1.
Sensitivity to mucidin of yeast strains with deletions
of PDR1 and PDR3 (A) or of PDR5 and
SNQ2 (B). The amount of mucidin applied to the paper disk
was 1 µg (A) and 0.5 µg (B). The bars represent the standard
deviations.
|
|
Whereas the disruption of the PDR1 and/or the
PDR3 gene led to an increased sensitivity of cells to
mucidin, all independently isolated gain-of-function mutations in the
PDR1 gene or in the PDR3 gene resulted in mucidin
resistance. In a genetic background of
pdr3 strains
(1), the most resistant was the strain containing the
chromosomal pdr1-3 allele and less resistant was the strain with the pdr1-6 allele (Fig.
2A). Different levels of mucidin resistance were also observed in the isogenic transformants of the
pdr1
pdr3 host strain FY1679-28C/TDEC bearing on a
centromeric plasmid the wild-type PDR3 gene or the
pdr3 mutant alleles containing mutations either in the
central regulatory domain (Fig. 2B) or in the C-terminal activation
domain (Fig. 2C).

View larger version (27K):
[in this window]
[in a new window]
|
FIG. 2.
Resistance to mucidin of the isogenic strains bearing
different pdr1 (A) and pdr3 (B and C) mutant
alleles. The amount of mucidin applied to the disk was 5 µg. The bars
represent the standard deviations.
|
|
Mucidin added to the wild-type strain FY1979-28C grown in minimal
glucose medium at a concentration (0.4 µg/ml) that inhibits cell
growth on nonfermentable carbon sources but does not affect the growth
on glucose induced an increased expression of PDR5. The
abundance of Pdr5p in cells grown in the presence of mucidin for 1 and
2 h was 2.0 and 2.7 times higher, respectively, than that in the
control cells (Fig. 3). Under similar
conditions, no significant changes were observed in the level of Snq2p,
indicating that mucidin is an inducer and apparently also a substrate
of Pdr5p in S. cerevisiae. A similar induction of expression
of the drug transporter genes like PDR5 (12),
SNQ2 (12), YOR1 (2), and
PDR12 (14) was already demonstrated by their
respective substrates
cycloheximide, cations,
4-nitroquinoline-N-oxide, reveromycin, and sorbate.

View larger version (21K):
[in this window]
[in a new window]
|
FIG. 3.
Immunological detection of Pdr5p and Snq2p in the
wild-type strain FY1679-28C exposed to mucidin.
|
|
To assess whether mucidin is a substrate for Pdr5p, the susceptibility
to mucidin was determined in the strains with deletion either of single
PDR5 and SNQ2 or simultaneously of both genes (9). As shown in Fig. 1B, in zone-of-inhibition assays the mucidin sensitivity of
snq2 disruptant YYMI-3 was only
slightly higher than that of the wild-type strain YPH500. Such a small change in mucidin sensitivity was not observed in the spot test experiments (Fig. 4). On the other hand,
in both experiments the
pdr5 strain YKKB-13 exhibited
clear hypersensitivity to mucidin which was faintly elevated when the
strain YYM3 possessed the disruptions in both genes (
pdr5
and
snq2) (Fig. 1B). However, the transformants of this
strain containing the pdr3-4 or the pdr3-7 allele
on the centromeric plasmid were still able to grow in the presence of
0.05 µg of mucidin per ml, which already prevented the growth of the
host strain with deletion simultaneously of both PDR5 and
SNQ2 (Fig. 4). Under the same conditions, no growth of the
wild-type strain YPH500,
pdr5
snq2 double mutant YYM3, and its transformants was observed at a mucidin concentration of 0.1 µg per ml (data not shown).

View larger version (38K):
[in this window]
[in a new window]
|
FIG. 4.
Mucidin susceptibility of the strain YYM3 with deletions
of PDR5 and SNQ2 and transformed with the
pdr3 mutant alleles. Cells were grown for 5 days at 30°C
on YPGE medium containing mucidin at concentrations of 0.025 (A) and
0.05 (B) µg/ml.
|
|
These results indicate that mucidin-inducible Pdr5p is a primary
membrane transporter responsible for mucidin resistance. Nevertheless, another as-yet-unidentified drug transporter
protein(s) different from that of Pdr5p and Snq2p but overexpressible
by the mutated Pdr3p can also modulate mucidin sensitivity. In fact, 29 members of the superfamily of ATP binding cassette transporters (3) and 28 members of the major facilitator
superfamily (6) were identified in the complete
S. cerevisiae genome. However, in comparison with Pdr5p
their contribution to mucidin efflux seems to be only marginal.
 |
ACKNOWLEDGMENTS |
We thank C. Jacq, A. Delahodde, E. Balzi, A. Goffeau, Y. Mahe, and
K. Kuchler for plasmids, strains, antibodies, and many helpful discussions.
This work was supported by grants from the Slovak Grant Agency of
Science (VEGA) and from the Slovak Ministry of Education. The research
of J.S. was also supported by an International Research Scholars Grant
from the Howard Hughes Medical Institute (U.S.A.).
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Microbiology and Virology, Faculty of Natural Sciences, Comenius
University, Mlynska dolina B-2, 842 15 Bratislava, Slovak Republic.
Phone: 4217 60296631. Fax: 4217 65429064. E-mail:
subik{at}fns.uniba.sk.
 |
REFERENCES |
| 1.
|
Carvajal, E.,
H. B. Van Den Hazel,
A. Cybularz-Kolaczkowska,
E. Balzi, and A. Goffeau.
1997.
Molecular and phenotypic characterization of yeast PDR1 mutants that show hyperactive transcription of various ABC multidrug transporter genes.
Mol. Gen. Genet.
256:406-415[CrossRef][Medline].
|
| 2.
|
Cui, Z.,
D. Hirata,
E. Tsuchiya,
H. Osada, and T. Miyakawa.
1996.
The multidrug resistance-associated protein (MRP) subfamily (Yrs1/Yor1) of Saccharomyces cerevisiae is important for the tolerance to a broad range of organic anions.
J. Biol. Chem.
271:14712-14716[Abstract/Free Full Text].
|
| 3.
|
Decottignies, A., and A. Goffeau.
1997.
Complete inventory of the yeast ABC proteins.
Nat. Genet.
15:137-145[CrossRef][Medline].
|
| 4.
|
Delaveau, T.,
A. Delahodde,
E. Carvajal,
J. Subik, and C. Jacq.
1994.
PDR3, a new yeast regulatory gene, is homologous to PDR1 and controls the multidrug resistance phenomenon.
Mol. Gen. Genet.
244:501-511[CrossRef][Medline].
|
| 5.
|
Egner, R.,
Y. Mahe,
R. Pandjaitan, and K. Kuchler.
1995.
Endocytosis and vacuolar degradation of the plasma membrane-localized Pdr5 ATP-binding cassette multidrug transporter in Saccharomyces cerevisiae.
Mol. Cell. Biol.
15:5879-5887[Abstract].
|
| 6.
|
Goffeau, A.,
J. Park,
I. T. Paulsen,
J. L. Jonniaux,
T. Dinh,
P. Mordant, and M. H. Saier, Jr.
1997.
Multidrug-resistant transport proteins in yeast: complete inventory and phylogenetic characterization of yeast open reading frames within the major facilitator superfamily.
Yeast
13:43-54[CrossRef][Medline].
|
| 7.
|
Kejda, J.
1976.
Mucidin ein neues antimyzetisches antibiotikum.
Castellania
4:193-194.
|
| 8.
|
Kolaczkowski, M., and A. Goffeau.
1997.
Active efflux by multidrug transporters as one of the strategies to evade chemotherapy and novel practical implications of yeast pleiotropic drug resistance.
Pharmacol. Ther.
76:219-242[CrossRef][Medline].
|
| 9.
|
Mahe, Y.,
Y. Lemoine, and K. Kuchler.
1996.
The ATP binding cassette transporters Pdr5 and Snq2 of Saccharomyces cerevisiae can mediate transport of steroids in vivo.
J. Biol. Chem.
271:25167-25172[Abstract/Free Full Text].
|
| 10.
|
Michalkova-Papajova, D., and J. Subik.
1999.
Mucidin clinically used antifungal antibiotic and a tool in the biological research.
Biol. Listy
64:137-156. (In Slovak.)
|
| 11.
|
Miyahara, K.,
D. Hirata, and T. Miyakawa.
1996.
yAP-1- and yAP-2-mediated, heat shock-induced transcriptional activation of the multidrug resistance ABC transporter genes in Saccharomyces cerevisiae.
Curr. Genet.
29:103-105[Medline].
|
| 12.
|
Miyahara, K.,
M. Mizunuma,
D. Hirata,
E. Tsuchiya, and T. Miyakawa.
1996b.
The involvement of the Saccharomyces cerevisiae multidrug resistance transporters Pdr5p and Snq2p in cation resistance.
FEBS Lett.
399:317-320[CrossRef][Medline].
|
| 13.
|
Nourani, A.,
D. Papajova,
A. Delahodde,
C. Jacq, and J. Subik.
1997.
Clustered amino acid substitutions in the yeast transcription regulator Pdr3p increase pleiotropic drug resistance and identify a new central regulatory domain.
Mol. Gen. Genet.
256:397-405[CrossRef][Medline].
|
| 14.
|
Piper, P.,
Y. Mahe,
S. Thompson,
R. Pandjaitan,
C. Holyoak,
R. Egner,
M. Muhlbauer,
P. Coote, and K. Kuchler.
1997.
The Pdr12 ABC transporter is required for the development of weak organic acid resistance in yeast.
EMBO J.
17:4257-4265[CrossRef][Medline].
|
| 15.
|
Sanglard, D.,
F. Ischer,
D. Calobrese,
M. de Micheli, and J. Bille.
1998.
Multiple resistance mechanisms to azole antifungals in yeast clinical isolates.
Drug Resist. Updates
1:255-265.
|
| 16.
|
Subik, J.,
M. Behun, and V. Musilek.
1974.
Antibiotic mucidin, a new antimycin A-like inhibitor of electron transport in rat liver mitochondria.
Biochem. Biophys. Res. Commun.
57:17-22[CrossRef][Medline].
|
| 17.
|
Subik, J.,
V. Kovacova, and G. Takacsova.
1977.
Mucidin resistance in yeast. Isolation, characterization and genetic analysis of nuclear and mitochondrial mucidin-resistant mutants of Saccharomyces cerevisiae.
Eur. J. Biochem.
73:275-286[Medline].
|
| 18.
|
Subik, J.,
S. Ulaszewski, and A. Goffeau.
1986.
Genetic mapping of nuclear mucidin resistance mutations in Saccharomyces cerevisiae. A new pdr locus on chromosome II.
Curr. Genet.
10:665-670[CrossRef][Medline].
|
Antimicrobial Agents and Chemotherapy, February 2000, p. 418-420, Vol. 44, No. 2
0066-4804/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Bammert, G. F., Fostel, J. M.
(2000). Genome-Wide Expression Patterns in Saccharomyces cerevisiae: Comparison of Drug Treatments and Genetic Alterations Affecting Biosynthesis of Ergosterol. Antimicrob. Agents Chemother.
44: 1255-1265
[Abstract]
[Full Text]